Literature DB >> 19302425

Awareness of hypertension and proteinuria in randomly selected patients in 11 Italian cities. A 2005 report of the National Kidney Foundation of Italy.

Andrea Galassi1, Diego Brancaccio, Mario Cozzolino, Guido Bellinghieri, Umberto Buoncristiani, Fosco Cavatorta, Ludovica D'Apice, Biagio Di Iorio, Loreto Gesualdo, Salvatore Gianni, Biagio Ricciardi, Domenico Russo, Vittorio Andreucci.   

Abstract

Arterial hypertension and proteinuria are risk factors for chronic kidney disease. A mobile clinic was parked in a central plaza of 11 Italian cities to check blood pressure (BP), prescribe antihypertensive drugs, assess for proteinuria, and provide awareness about hypertension. Among 3757 patients, 56% were hypertensive, 37% were not diabetic nor proteinuric with BP >or=140/90 mm Hg, 17% were diabetic or proteinuric with BP >or=130/80 mm Hg, and 11% were on treatment with BP at target. Among 1204 treated patients, 400 (33%) had controlled BP. Among all 2114 hypertensive patients, only 1344 (64%) were aware of their hypertension. Awareness was greater among treated patients at target (99%). As many as 523 (14%) patients had proteinuria >or=30 mg/dL. The authors conclude that awareness of people walking in the street about their BP and proteinuria is insufficient. Mobile screening clinics may increase public awareness and detection of hypertension and proteinuria in the general community and detect patients at risk for chronic kidney disease.

Entities:  

Mesh:

Year:  2009        PMID: 19302425      PMCID: PMC8673291          DOI: 10.1111/j.1751-7176.2009.00081.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  37 in total

1.  Excerpts from the United States Renal Data System 2006 Annual Data Report.

Authors:  Allan J Collins; Bertram Kasiske; Charles Herzog; Blanche Chavers; Robert Foley; David Gilbertson; Richard Grimm; Jiannong Liu; Thomas Louis; Willard Manning; Marshall McBean; Anne Murray; Wendy St Peter; Jay Xue; Qiao Fan; Haifeng Guo; Qi Li; Shuling Li; Yang Qiu; Suying Li; Tricia Roberts; Melissa Skeans; Jon Snyder; Craig Solid; Changchun Wang; Eric Weinhandl; Rui Zhang; Cheryl Arko; Shu-Cheng Chen; Frederick Dalleska; Frank Daniels; Stephan Dunning; James Ebben; Eric Frazier; Christopher Hanzlik; Roger Johnson; Daniel Sheets; Xinyue Wang; Beth Forrest; Delaney Berrini; Edward Constantini; Susan Everson; Paul Eggers; Lawrence Agodoa
Journal:  Am J Kidney Dis       Date:  2007-01       Impact factor: 8.860

2.  Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy.

Authors:  Peter Jacobsen; Steen Andersen; Kasper Rossing; Berit R Jensen; Hans-Henrik Parving
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

3.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

4.  Report on management of renal failure in Europe, XXIV, 1993.

Authors:  F Valderrábano; E H Jones; N P Mallick
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

5.  Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.

Authors:  Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Jonathan N Bella; Tapio Aalto; Björn Dahlöf; Eva Gerdts; Jackson T Wright; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen; Richard B Devereux
Journal:  Am Heart J       Date:  2002-02       Impact factor: 4.749

Review 6.  Screening for chronic kidney disease: where does Europe go?

Authors:  Paul E de Jong; Marije van der Velde; Ron T Gansevoort; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 8.237

7.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

Review 9.  Longitudinal Study of the National Kidney Foundation's (NKF) Kidney Early Evaluation Program (KEEP).

Authors:  Suzanne E Ohmit; John M Flack; Rosalind M Peters; Wendy W Brown; Richard Grimm
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

10.  A project to prevent renal diseases in the general population.

Authors:  Domenico Russo; Paola Napolitano; Maria Luisa Sirico; Vittorio E Andreucci
Journal:  J Nephrol       Date:  2007 Jan-Feb       Impact factor: 3.902

View more
  1 in total

1.  The potential of mobile health clinics in chronic disease prevention and health promotion in universal healthcare systems. An on-field experiment.

Authors:  Chiara Bertoncello; Silvia Cocchio; Marco Fonzo; Silvia Eugenia Bennici; Francesca Russo; Giovanni Putoto
Journal:  Int J Equity Health       Date:  2020-05-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.